DHEA adverse event reports to FDA cite reactions ranging from acne to tachycardia.
This article was originally published in The Tan Sheet
Executive Summary
DHEA ADVERSE EVENT REPORTS TO FDA link the dietary supplement to reactions ranging from acne to tachycardia, according to the most recently updated version of the FDA Office of Special Nutritionals Adverse Event Monitoring Systems database. Fifteen reports listed in the first half of 1997 link DHEA, or dehydroepiandrosterone, with acne, fatigue, rash, macular eruption, increased ocular pressure, increased heart rate, hepatitis, venous distention, tachycardia and palpitations.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: